Gadoxetate-enhanced Abbreviated MRI for Hepatocellular Carcinoma Surveillance: Preliminary Experience

Abstract

Gadoxetate-enhanced abbreviated MRI is feasible clinically, has a high diagnostic adequacy rate, and, on the basis of our preliminary experience, accurately depicts HCC in high-risk patients. Strategies to enhance follow-up compliance are needed.© RSNA, 2019<b>Keywords:</b> Abdomen/GI, Cirrhosis, Liver, MR-Imaging, Oncology, Screening<i>Supplemental material is available for this article.</i>